No Title Presenter Date
1307 RIKS HIA Survival benefits by 12 years registry supported improvement of acute cardiac care in the Sweden - the RIKS-HIA 12 years study Oct. 18. 10
1306 Remote preconditioning reflex - a neural pathway of cardioprotection during myocardial ischaemia and reperfusion induced by remote ischaemic preconditioning Oct. 18. 10
1305 PLATO genetic substudy Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in ACS - a PLATO genetic substudy Oct. 18. 10
1304 MULTI STRATEGY 3-year F-U of the Comparison of Angioplasty with Tirofiban or Abciximab and with Implantation of Sirolimus-Eluting or Uncoated Stents for AMI Oct. 18. 10
1303 LESSON I Long-term comparison of Everolimus-eluting and Sirolimus-eluting Stents for coronary revascularization Oct. 18. 10
1302 ISAR TEST 4 Two-year Clinical Outcomes from a Randomized Trial of Biodegradable Polymer Drug-Eluting Stents Versus Permanent Polymer Cypher and Xience Drug-Eluting Stents Oct. 18. 10
1301 ISAR REACT 3A A trial of reduced dose of unfractionated heparin in patients undergoing percutaneous coronary interventions Oct. 18. 10
1300 INNOVATE PCI A Phase II Safety and Efficacy Study of PRT060128 (Elinogrel), a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI. Oct. 18. 10
1299 HEBE III A single dose of erythropoietin in ST-elevation myocardial infarction Oct. 18. 10
1298 GRACE Five year outcomes (UK Belgian collaboration) Oct. 18. 10